Historical Stock Price
ADVM historical stock prices picture
Adverum Biotechnologies (ADVM) has the following price history information. Looking back at ADVM historical stock prices for the last five trading days, on March 21, 2024, ADVM opened at $15.69, traded as high as $17.65 and as low as $14.52, and closed at $14.75. Trading volume was a total of 256.70K shares. On March 22, 2024, ADVM opened at $14.31, traded as high as $16.48 and as low as $14.00, and closed at $16.06. Trading volume was a total of 576.60K shares. On March 25, 2024, ADVM opened at $15.75, traded as high as $16.43 and as low as $14.86, and closed at $14.95. Trading volume was a total of 357.30K shares. On March 26, 2024, ADVM opened at $14.92, traded as high as $14.92 and as low as $13.67, and closed at $14.15. Trading volume was a total of 682.60K shares. On March 27, 2024, ADVM opened at $14.16, traded as high as $15.16 and as low as $13.73, and closed at $14.66. Trading volume was a total of 166.90K shares.

ADVM Historical Stock Prices By Date:

ADVM historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adverum Biotechnologies shares, starting with a $10,000 purchase of ADVM, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/01/2014
End date: 03/27/2024
Start price/share: $251.60
End price/share: $14.66
Dividends collected/share: $0.00
Total return: -94.17%
Average Annual Total Return: -25.49%
Starting investment: $10,000.00
Ending investment: $582.85
Years: 9.66
Date Open High Low Close Volume
03/21/2024 $15.69 $17.65 $14.52 $14.75 256.70K
03/22/2024 $14.31 $16.48 $14.00 $16.06 576.60K
03/25/2024 $15.75 $16.43 $14.86 $14.95 357.30K
03/26/2024 $14.92 $14.92 $13.67 $14.15 682.60K
03/27/2024 $14.16 $15.16 $13.73 $14.66 166.90K
Adverum Biotechnologies is a clinical-stage company focused on establishing gene therapy as a standard of care for ocular diseases. Co.'s main product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product. Ixo-vec is being developed for the treatment of patients with wet age-related macular degeneration who are responsive to anti-vascular endothelial growth factor therapy. Co.'s second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy via a single IVT injection.
Date Close
03/21/2024$14.75
03/22/2024$16.06
03/25/2024$14.95
03/26/2024$14.15
03/27/2024$14.66
ADVM is categorized under the Healthcare sector; below are some other companies in the same sector:

ADXS Historical Stock Prices
AEGR Historical Stock Prices
AEMD Historical Stock Prices
AERI Historical Stock Prices
AEZS Historical Stock Prices
AFAM Historical Stock Prices
AFFX Historical Stock Prices
AGEN Historical Stock Prices
AGIO Historical Stock Prices
AGLE Historical Stock Prices

Also explore: ADVM shares outstanding history

Email EnvelopeFree ADVM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ADVM Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.